HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

COVID Spells ‘The End Of Influencers’? Not Remotely, But The Game Is Changing

Executive Summary

Market analysts and forecasters discuss the evolving role of influencers, which COVID-19 has affected like virtually everything else.

You may also be interested in...



L’Oreal Says Makeup Will Be Back, But ‘Health Is The Future Of Beauty’

Dermocosmetics was L’Oreal’s biggest growth story in 2020, benefiting from shifting consumer priorities during the COVID crisis and reinvigorated faith in the recommendations of healthcare professionals. Makeup sales tanked, but that could well reverse with the advent of another Roaring Twenties post-pandemic, L’Oreal leadership suggests.

E.l.f. Cosmetics Making Splash On Triller Now, Following Viral TikTok Hits

Affordable, prestige-inspired cosmetics maker e.l.f. Cosmetics had four songs on Billboard’s Top Triller Global list for the week of 2 January, all remixed holiday classics featuring rising talent in the music industry. The Triller campaign reinforces e.l.f.'s reputation as a social media pioneer in the beauty sector.

Hawaii Puts Hold On Proposal To Blacklist Additional Sunscreen Ingredients

Proposed bills in the Aloha State would ban the sale of sunscreens containing octocrylene and/or avobenzone, adding to a UV filter blacklist that already includes oxybenzone and octinoxate. On 17 February, Hawaiian legislators elected to defer the legislation to await completion of a National Academy of Sciences study, targeted for 2022.

Topics

UsernamePublicRestriction

Register

LL1135307

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel